Single Source for the Continuation of the Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U2C Clinical Trial Not Allowed)
ID: 353422Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Public and State Controlled Institutions of Higher Education

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353422

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-TR-24-021.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity for a single-source cooperative agreement to the Cincinnati Children's Hospital Medical Center (CCHMC) for the continuation of the Data Management and Coordinating Center (DMCC) supporting the Rare Diseases Clinical Research Network (RDCRN). This initiative aims to enhance the diagnosis, management, and treatment of various rare diseases through collaborative, multi-site research, providing essential administrative, data management, clinical research support, and broad dissemination of findings across a network of over 280 institutions. The program emphasizes non-competitive funding due to the significant investment already made in establishing a cohesive infrastructure, with a total funding commitment of $3.5 million over a project period of up to five years. Interested applicants can find more information and guidelines for application submission at the NIH grants website, with the application deadline set for July 22, 2024.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-TR-24-021.html
    The Department of Health and Human Services issues a funding opportunity for a single-source cooperative agreement to the Cincinnati Children's Hospital Medical Center (CCHMC) for the continuation of the Data Management and Coordinating Center (DMCC) supporting the Rare Diseases Clinical Research Network (RDCRN). This initiative aims to enhance diagnosis, management, and treatment of various rare diseases via collaborative, multi-site research. The DMCC will provide essential administrative, data management, research support, and broad dissemination of findings across a network of over 280 institutions. Key features of the program include the integration of cloud computing resources, established data standards based on FAIR principles, and engagement with patient advocacy groups. Through a structured approach involving multiple cores—administrative, data management, clinical research, and engagement—CCHMC will ensure effective collaboration and data accessibility for community stakeholders. The notice emphasizes non-competitive funding, citing the significant investment already made in establishing a cohesive infrastructure. The opportunity includes guidelines for application submission and adherence to specific requirements, such as maintaining eligibility and registrations with relevant federal systems, with a project period of up to five years and a combined funding commitment of $3.5 million from NCATS and NINDS.
    Similar Opportunities
    Notice of Intent to Publish a Notice of Funding Opportunity (NOFO) for the Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Rare Diseases Clinical Research Consortia (RDCRC) as part of the Rare Diseases Clinical Research Network (RDCRN). This initiative aims to solicit applications for collaborative, multi-site research focused on advancing the diagnosis, management, and treatment of rare diseases, with an emphasis on addressing unmet clinical trial readiness needs. The funding, estimated at $1 million, will support specialized centers through cooperative agreements, with the NOFO expected to be published in winter 2024 and applications due in summer 2024. Interested applicants should prepare to develop meaningful collaborations, as the estimated award date is set for July 1, 2025.
    Notice of Intent to Publish a Funding Opportunity Announcement for the Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN)
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Funding Opportunity Announcement (FOA) for the Rare Diseases Clinical Research Consortia (RDCRC) as part of the Rare Diseases Clinical Research Network (RDCRN). This initiative aims to enhance the diagnosis, management, and treatment of rare diseases through collaborative, multi-site, patient-centric research, with a focus on addressing unmet clinical trial readiness needs. The estimated total program funding for this opportunity is $1,000,000, with the FOA expected to be published in 2024 and applications due later that year. Interested applicants can reach out to Dr. Tiina K. Urv at 301-827-2746 or via email at urvtiin@mail.nih.gov for further information.
    Single Source: Bench to Bassinet Congenital Heart disease Advancing New understanding in GEnomics Cohort (B2B CHANGE Cohort) Data Coordinating Center (U01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for a single-source cooperative agreement aimed at establishing the B2B CHANGE Cohort Data Coordinating Center, transitioning from the existing Bench-to-Bassinet (B2B) Program. This initiative, primarily awarded to Cincinnati Children's Hospital Medical Center, focuses on advancing the understanding of congenital heart disease (CHD) through the analysis of genomic and clinical data from over 13,000 individuals, with an emphasis on deep phenotyping and longitudinal studies to improve clinical outcomes. The project aims to enhance community engagement, ensure data availability for the scientific community, and promote diversity in research participation, with a mandatory Plan for Enhancing Diverse Perspectives (PEDP) required from applicants. Interested parties should note that the funding ceiling is set at $4,010,000, with applications due by March 18, 2025. For further inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed)" aimed at enhancing resources for investigating undiagnosed diseases through a network of clinical sites. This initiative seeks to designate successful applicants as Diagnostic Centers of Excellence (DCoE), which will be responsible for generating clinical data to be shared with the Data Management Coordinating Center (DMCC), thereby promoting collaboration among clinicians and researchers to improve diagnostic capabilities, particularly for health disparity populations. The program does not provide direct budgetary support but allows successful applicants to apply for subawards for research activities, with applications open from April 15, 2023, until the final deadline of May 15, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the Natural Product Multi-Site Clinical Trial Data Coordinating Center (DCC) through a cooperative agreement mechanism. This initiative invites applications for a DCC that will collaborate with a Clinical Coordinating Center (CCC) to conduct multi-site clinical trials focused on the efficacy and effectiveness of natural products, requiring simultaneous submission of both applications. The program emphasizes the importance of maintaining data integrity, promoting diversity in participant recruitment, and achieving specific milestones for continued funding, while also necessitating a Plan for Enhancing Diverse Perspectives (PEDP) to ensure inclusivity in research. Interested applicants can find more information and application details on the NIH grants website, with a submission deadline of July 14, 2026, and a contact email for inquiries at grantsinfo@nih.gov.
    Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Data Coordinating Center (DCC) for multi-site investigator-initiated clinical trials under funding opportunity PAR-22-193. This initiative aims to support trials that evaluate efficacy, comparative effectiveness, and implementation strategies relevant to the mission of the National Heart, Lung, and Blood Institute (NHLBI), emphasizing collaboration with a Clinical Coordinating Center (CCC). The DCC will be responsible for comprehensive project coordination, data management, and biostatistical support, ensuring adherence to participant safety and diverse population recruitment. Interested applicants must submit both DCC and CCC applications concurrently by September 11, 2025, and can seek early consultation with NIH staff for guidance. For further details, applicants can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov or visit the additional information link at http://grants.nih.gov/grants/guide/pa-files/PAR-22-193.html.
    Limited Competition: Research Centers in Minority Institutions (RCMI) Coordinating Center (U24 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a limited competition federal grant opportunity titled "Research Centers in Minority Institutions (RCMI) Coordinating Center," aimed at establishing a national coordinating center to enhance research capacity at RCMI institutions. The center will facilitate collaboration among approximately 22 RCMI Specialized Centers, focusing on securing extramural funding and fostering environments conducive to successful research careers, particularly in addressing health disparities affecting minority populations. This initiative is crucial for promoting high-quality biomedical, behavioral, and clinical research while supporting investigators from underrepresented backgrounds. The total funding available for this opportunity is $3.5 million, with applications due by January 25, 2025. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), is offering a funding opportunity titled "NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)." This initiative aims to support high-risk, investigator-initiated, multi-center clinical studies by facilitating early peer review and the development of essential operational documents necessary for conducting the proposed studies. The program emphasizes the importance of addressing diseases affecting underrepresented populations and requires applicants to include a Plan for Enhancing Diverse Perspectives (PEDP) in their submissions. The maximum award amount is $225,000 per year for up to two years, with applications opening on May 9, 2025, and a submission deadline of June 10, 2027. Interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Center for Complementary and Integrative Health (NCCIH), is inviting applications for a Data Coordinating Center (DCC) to support multi-site, investigator-initiated clinical trials focused on mind and body interventions. The DCC will be responsible for project coordination, administrative support, data management, and biostatistical analysis for Phase III clinical trials, and must be submitted alongside a Clinical Coordinating Center (CCC) proposal. This initiative is crucial for advancing research in complementary and integrative health strategies that address public health challenges, emphasizing participant diversity and data integrity. Interested applicants should note that the application deadline is January 20, 2025, with a funding period of up to 7 years, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Limited Competition: NCI National Clinical Trials Network - Network Group Statistics and Data Management Centers (U10 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for the Limited Competition: NCI National Clinical Trials Network - Network Group Statistics and Data Management Centers (U10 Clinical Trial Required). This initiative invites applications primarily from current award recipients under RFA-CA-17-057 to sustain Statistics and Data Management Centers (SDMCs) for the NCI National Clinical Trials Network (NCTN), which focuses on advancing cancer treatment through multi-center clinical trials, particularly late-phase trials and biomarker-driven therapies. The funding, totaling approximately $47 million, aims to support five awards over a project period of up to six years, emphasizing the need for substantial Federal scientific involvement and robust statistical analysis plans. Interested applicants must submit their proposals by January 24, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.